Abstract
Efficacy of ubrogepant for the treatment of migraine symptoms during the prodrome (premonitory phase): Results from the prodrome trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.jns.2023.121630
Journal: Journal of the Neurological Sciences | Publication Date: Dec 1, 2023 |
Efficacy of ubrogepant for the treatment of migraine symptoms during the prodrome (premonitory phase): Results from the prodrome trial
Join us for a 30 min session where you can share your feedback and ask us any queries you have